92 related articles for article (PubMed ID: 6728894)
21. Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Marriott JH; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1997 May; 40(10):1495-510. PubMed ID: 9154971
[TBL] [Abstract][Full Text] [Related]
22. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.
Supuran CT; Casini A; Scozzafava A
Med Res Rev; 2003 Sep; 23(5):535-58. PubMed ID: 12789686
[TBL] [Abstract][Full Text] [Related]
23. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
[TBL] [Abstract][Full Text] [Related]
24. Acyclic analogues of 5-fluoro-dUMP and 5-fluoro-2'-deoxyuridine: synthesis and inhibition of thymidylate synthase and tumour cell growth.
Felczak K; Gołos B; Dzik JM; Rode W; Bretner M; Shugar D; Kulikowski T
Acta Biochim Pol; 1998; 45(1):75-82. PubMed ID: 9701498
[TBL] [Abstract][Full Text] [Related]
25. dUTP pyrophosphatase as a potential target for chemotherapeutic drug development.
McIntosh EM; Haynes RH
Acta Biochim Pol; 1997; 44(2):159-71. PubMed ID: 9360704
[TBL] [Abstract][Full Text] [Related]
26. Newer penicillins and beta-lactamase inhibitors.
Bush LM; Calmon J; Johnson CC
Infect Dis Clin North Am; 1995 Sep; 9(3):653-86. PubMed ID: 7490438
[TBL] [Abstract][Full Text] [Related]
27. Contributions of protein structure-based drug design to cancer chemotherapy.
Jackson RC
Semin Oncol; 1997 Apr; 24(2):164-72. PubMed ID: 9129687
[TBL] [Abstract][Full Text] [Related]
28. Promising new agents for treatment of patients with colorectal cancer.
Von Hoff DD
Semin Oncol; 1998 Oct; 25(5 Suppl 11):47-52. PubMed ID: 9786316
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of thymidylate synthase in chemotherapy].
Rode W
Postepy Biochem; 1996; 42(2):133-40. PubMed ID: 8805186
[No Abstract] [Full Text] [Related]
30. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
McGuire JJ; Magee KJ; Russell CA; Canestrari JM
Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
[TBL] [Abstract][Full Text] [Related]
31. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
33. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843.
Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK
Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962
[TBL] [Abstract][Full Text] [Related]
34. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
Papamichael D
Stem Cells; 2000; 18(3):166-75. PubMed ID: 10840069
[TBL] [Abstract][Full Text] [Related]
35. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
Calvert H
Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
[No Abstract] [Full Text] [Related]
36. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
37. Semisynthetic beta-lactam antibiotics. 3. Structure-activity relationships of alpha-sulfopenicillins.
Morimoto S; Nomura H; Fugono T; Minami I; Ishiguro T
J Antibiot (Tokyo); 1973 Mar; 26(3):146-52. PubMed ID: 4783198
[No Abstract] [Full Text] [Related]
38. Inhibition of thymidylate synthetase by some analogs of tetrahydrofolic acid.
Slavik K; Zakrzewski SF
Mol Pharmacol; 1967 Jul; 3(4):370-7. PubMed ID: 6033635
[No Abstract] [Full Text] [Related]
39. [Advances in the development of new cytostatics (author's transl)].
Semonský M
Cas Lek Cesk; 1976 Nov; 115(45):1380-5. PubMed ID: 1000545
[No Abstract] [Full Text] [Related]
40. Some considerations in the design of new antineoplastic agents.
Handschumacher RE
Cancer; 1977 Jul; 40(1 Suppl):529-33. PubMed ID: 884650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
